Are There Success Stories in Orphan Drugs for Cancer?
Yes, there have been notable success stories in the development of orphan drugs for cancer. For example, Imatinib (Gleevec) was developed for chronic myeloid leukemia (CML) and has significantly improved survival rates. Another example is Brentuximab Vedotin (Adcetris), which is used to treat Hodgkin lymphoma and anaplastic large cell lymphoma.
